AAAAAA

   
Results: 1-24 |
Results: 24
PERCUTANEOUS HEPATIC INFARCTION THERAPY FOR HEPATOCELLULAR-CARCINOMA
Authors: IMAMURA M SHIRATORI Y SATO S OBI S OKUDAIRA T TERATANI T KATO N SHIINA S OMATA M
Citation: M. Imamura et al., PERCUTANEOUS HEPATIC INFARCTION THERAPY FOR HEPATOCELLULAR-CARCINOMA, American journal of roentgenology, 171(4), 1998, pp. 1031-1035
POSITIONAL RELATIONSHIP BETWEEN THE PRIMARY LESION OF HEPATOCELLULAR-CARCINOMA AND ITS RECURRENCE
Authors: SHIINA S IMAMURA M TERATANI T OBI S HAMAMURA K SATO S YOSHIDA H KOIKE Y DAN Y KATO N YOSHIDA H KAWABE T SHIRATORI Y OMATA M
Citation: S. Shiina et al., POSITIONAL RELATIONSHIP BETWEEN THE PRIMARY LESION OF HEPATOCELLULAR-CARCINOMA AND ITS RECURRENCE, Hepatology, 28(4), 1998, pp. 347-347
POWER DOPPLER SONOGRAPHY FOR HEPATOCELLULAR-CARCINOMA - FACTORS AFFECTING THE POWER DOPPLER SIGNALS OF THE TUMORS
Authors: IMAMURA M SHIRATORI Y SHIINA S TERATANI T HAMAMURA K OBI S SATO S OKUDAIRA T KOIKE Y AKAMATSU M KATO N AKAHANE M OHTOMO K MINAMI M OMATA M
Citation: M. Imamura et al., POWER DOPPLER SONOGRAPHY FOR HEPATOCELLULAR-CARCINOMA - FACTORS AFFECTING THE POWER DOPPLER SIGNALS OF THE TUMORS, Hepatology, 28(4), 1998, pp. 2388-2388
QUANTITATIVE-ANALYSIS OF RAS GENE MUTATION IN PANCREATIC-JUICE FOR DIAGNOSIS OF PANCREATIC ADENOCARCINOMA
Authors: TADA M TERATANI T KOMATSU Y KAWABE T SHIRATORI Y OMATA M
Citation: M. Tada et al., QUANTITATIVE-ANALYSIS OF RAS GENE MUTATION IN PANCREATIC-JUICE FOR DIAGNOSIS OF PANCREATIC ADENOCARCINOMA, Digestive diseases and sciences, 43(1), 1998, pp. 15-20
ISCHEMIC STROKE DURING ANTICOAGULATION THERAPY - ITS RELATIONSHIP WITH INR VALUES DURING THE LAST 6 MONTHS PRIOR TO STROKE
Authors: KONDO K KINUGAWA H NARITOMI H YANAGIMOTO S TERATANI T YAMAWAKI T MINEMATSU K
Citation: K. Kondo et al., ISCHEMIC STROKE DURING ANTICOAGULATION THERAPY - ITS RELATIONSHIP WITH INR VALUES DURING THE LAST 6 MONTHS PRIOR TO STROKE, Stroke, 29(1), 1998, pp. 10-10
TO WHAT EXTENT SHOULD ONE TRY TO LOWER TUMOR-MARKERS IN TREATING HEPATOCELLULAR-CARCINOMA
Authors: HAMAMURA K SHIINA S IMAMURA M TERATANI T OBI S SATO S YOSHIDA H KOIKE Y DAN Y OKUDAIRA T KATO N YOSHIDA H KAWABE T SHIRATORI Y OMATA M
Citation: K. Hamamura et al., TO WHAT EXTENT SHOULD ONE TRY TO LOWER TUMOR-MARKERS IN TREATING HEPATOCELLULAR-CARCINOMA, Gastroenterology, 114(4), 1998, pp. 218-218
PERCUTANEOUS INFARCTION THERAPY (PIT) FOR HEPATOCELLULAR-CARCINOMA (HCC)
Authors: IMAMURA M SHIINA S TERATANI T OBI S SATO S KAMAMURA K KOIKE Y DAN Y YOSHIDA H OKUDAIRA T KANAI F KATO N YOSHIDA H KAWABE T SHIRATORI Y OMATA M
Citation: M. Imamura et al., PERCUTANEOUS INFARCTION THERAPY (PIT) FOR HEPATOCELLULAR-CARCINOMA (HCC), Gastroenterology, 114(4), 1998, pp. 262-262
EARLY DETECTION OF HEMOBILIA FOLLOWING PERCUTANEOUS ETHANOL INJECTIONTHERAPY FOR HEPATOCELLULAR-CARCINOMA - HEMOBILIA SIGN OF GALLBLADDER
Authors: OBI S SHIINA S IMAMURA M TERATANI T HAMAMURA K SATO S YOSHIDA H KOIKE Y DAN Y AKAMATSU M GOTO T OKUDAIRA G KATO N NIWA Y SHIRATORI Y OMATA M
Citation: S. Obi et al., EARLY DETECTION OF HEMOBILIA FOLLOWING PERCUTANEOUS ETHANOL INJECTIONTHERAPY FOR HEPATOCELLULAR-CARCINOMA - HEMOBILIA SIGN OF GALLBLADDER, Gastroenterology, 114(4), 1998, pp. 474-474
COLOR DOPPLER SIGNALS AFTER TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)TO EVALUATE RESPONSE TO TREATMENT FOR HEPATOCELLULAR-CARCINOMA (HCC)
Authors: SATO S SHIINA S IMAMURA M TERATANI T OBI S HAMAMURA K YOSHIDA H KOIKE Y DAN Y OKUDAIRA T KATO N KAWABE T YOSHIDA H SHIRATORI Y OMATA M
Citation: S. Sato et al., COLOR DOPPLER SIGNALS AFTER TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)TO EVALUATE RESPONSE TO TREATMENT FOR HEPATOCELLULAR-CARCINOMA (HCC), Gastroenterology, 114(4), 1998, pp. 554-554
COMPLETE ABLATION OF COLOR DOPPLER SIGNALS TO EVALUATE RESPONSE TO TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION FOR HEPATOCELLULAR-CARCINOMA
Authors: SATO S SHIINA S IMAMURA M TERATANI T OBI S HAMAMURA K YOSIDA H KOIKE Y DAN Y KAWABE T OKUDAIRA T KATO N YOSIDA H SHIRATORI Y OMATA M
Citation: S. Sato et al., COMPLETE ABLATION OF COLOR DOPPLER SIGNALS TO EVALUATE RESPONSE TO TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION FOR HEPATOCELLULAR-CARCINOMA, Gastroenterology, 114(4), 1998, pp. 555-555
PERCUTANEOUS ETHANOL INJECTION THERAPY FOR PATIENTS WITH HEPATOCELLULAR-CARCINOMA (HCC) WHOSE SERUM TOTAL BILIRUBIN LEVELS WERE 2.0 MG DL OR MORE/
Authors: SHIINA S IMAMURA M TERATANI T OBI S HAMAMURA K SATO S YOSHIDA H KOIKE Y DAN Y KATO N NIWA Y OKUDAIRA T YOSHIDA H KAWABE T SHIRATORI Y OMATA M
Citation: S. Shiina et al., PERCUTANEOUS ETHANOL INJECTION THERAPY FOR PATIENTS WITH HEPATOCELLULAR-CARCINOMA (HCC) WHOSE SERUM TOTAL BILIRUBIN LEVELS WERE 2.0 MG DL OR MORE/, Gastroenterology, 114(4), 1998, pp. 587-587
SIGNIFICANCE OF TUMOR-MARKERS FOR HEPATOCELLULAR-CARCINOMA, ALPHA-FETOPROTEIN AND DESGAMMACARBOXY PROTHROMBIN, IN THE ERA OF DIAGNOSTIC IMAGINGS
Authors: HAMAMURA K SHUNA S IMAMURA M TERATANI T OBI S SATO S YOSHIDA H KATO N KANAI F TOGO G NIWA Y SHIRATORI Y OMATA M
Citation: K. Hamamura et al., SIGNIFICANCE OF TUMOR-MARKERS FOR HEPATOCELLULAR-CARCINOMA, ALPHA-FETOPROTEIN AND DESGAMMACARBOXY PROTHROMBIN, IN THE ERA OF DIAGNOSTIC IMAGINGS, Gastroenterology, 112(4), 1997, pp. 574-574
PERCUTANEOUS MICROWAVE ABLATION THERAPY FOR HEPATOCELLULAR-CARCINOMA
Authors: SHIINA S IMAMURA M TERATANI T OBI S TOUGOU G HAMAMURA K SATO S YOSHIDA H KATO N KANAI F OKUDAIRA G PAYAWAL DA TATEISHI R SHIRATORI Y OMATA M
Citation: S. Shiina et al., PERCUTANEOUS MICROWAVE ABLATION THERAPY FOR HEPATOCELLULAR-CARCINOMA, Gastroenterology, 112(4), 1997, pp. 655-655
PERCUTANEOUS ETHANOL INJECTION THERAPY FOR HEPATOCELLULAR-CARCINOMA -A 10-YEAR EXPERIENCE
Authors: SHIINA S IMAMURA M TATEISHI R TERATANI T SHIRATORI Y OMATA M
Citation: S. Shiina et al., PERCUTANEOUS ETHANOL INJECTION THERAPY FOR HEPATOCELLULAR-CARCINOMA -A 10-YEAR EXPERIENCE, Radiology, 201, 1996, pp. 657-657
QUANTITATIVE-ANALYSIS OF RAS GENE MUTATION IN PANCREATIC-JUICE FOR DIAGNOSIS OF PANCREATIC ADENOCARCINOMA
Authors: TADA M TERATANI T KOMATSU Y KAWABE T SHIRATORI Y OMATA M
Citation: M. Tada et al., QUANTITATIVE-ANALYSIS OF RAS GENE MUTATION IN PANCREATIC-JUICE FOR DIAGNOSIS OF PANCREATIC ADENOCARCINOMA, Gastroenterology, 110(4), 1996, pp. 599-599
HISTOLOGICAL CHARACTERIZATION OF ULTRASONICALLY HIGH ECHO FOCI IN CHRONIC LIVER-DISEASES
Authors: YAMAGATA M OKUDAIRA T IMAMURA M TERATANI T KANAI F KATO N SHIINA S SHIRATORI Y OMATA M
Citation: M. Yamagata et al., HISTOLOGICAL CHARACTERIZATION OF ULTRASONICALLY HIGH ECHO FOCI IN CHRONIC LIVER-DISEASES, Gastroenterology, 110(4), 1996, pp. 616-616
ENDOSCOPIC VARICEAL LIGATION IS A SUFFICIENT PROCEDURE FOR THE TREATMENT OF ESOPHAGEAL-VARICES IN PATIENTS WITH HEPATITIS-C LIVER-CIRRHOSIS- COMPARISON WITH INJECTION SCLEROTHERAPY
Authors: HATA Y HAMADA E OGURA K OTA S SHIINA S TAKAHASHI M SATO S TERATANI T MATSUKAWA S KAWASE T NOMURA M KAWABE T SHIRATORI Y OMATA M
Citation: Y. Hata et al., ENDOSCOPIC VARICEAL LIGATION IS A SUFFICIENT PROCEDURE FOR THE TREATMENT OF ESOPHAGEAL-VARICES IN PATIENTS WITH HEPATITIS-C LIVER-CIRRHOSIS- COMPARISON WITH INJECTION SCLEROTHERAPY, Gastroenterology, 110(4), 1996, pp. 1206-1206
EXPRESSION OF THROMBOPOIETIN MESSENGER-RNA IN THE LIVER OF THE PATIENTS WITH CHRONIC LIVER-DISEASE
Authors: KATO N NITA S IMAMURA M TERATANI T KANAI F MATSUMURA M NIWA Y SHIINA S ZHANG PY YOSHIDA H SHIRATORI Y OMATA M
Citation: N. Kato et al., EXPRESSION OF THROMBOPOIETIN MESSENGER-RNA IN THE LIVER OF THE PATIENTS WITH CHRONIC LIVER-DISEASE, Gastroenterology, 110(4), 1996, pp. 1230-1230
BENEFIT OF ENDOSCOPIC PAPILLARY BALLOON DILATATION (EPBD) FOR TREATING PATIENTS WITH LIVER-CIRRHOSIS HEPATOCELLULAR-CARCINOMA (HCC) MANIFESTING OBSTRUCTIVE-JAUNDICE
Authors: OHASHI M KOMATSU K TOGO G TODA N TERATANI T IMAMURA M KANAI F OKUDAIRA T KATO N MATSUMURA M TADA M SIINA S NIWA Y KAWABE T SHIRATORI Y OMATA M
Citation: M. Ohashi et al., BENEFIT OF ENDOSCOPIC PAPILLARY BALLOON DILATATION (EPBD) FOR TREATING PATIENTS WITH LIVER-CIRRHOSIS HEPATOCELLULAR-CARCINOMA (HCC) MANIFESTING OBSTRUCTIVE-JAUNDICE, Gastroenterology, 110(4), 1996, pp. 1283-1283
PERCUTANEOUS ETHANOL INJECTION THERAPY FOR HEPATOCELLULAR-CARCINOMA
Authors: SHIINA S IMAMURA M TERATANI T OBI S KATO N KANAI F NIWA Y OKUDAIRA T KAWABE T OTA S SHIRATORI Y OMATA M
Citation: S. Shiina et al., PERCUTANEOUS ETHANOL INJECTION THERAPY FOR HEPATOCELLULAR-CARCINOMA, Gastroenterology, 110(4), 1996, pp. 1322-1322
COINFECTION OF HEPATITIS-B AND HEPATITIS-C VIRUSES PLAYS MUCH LESS ROLE IN DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA (HCC) THAN GENERALLY CLAIMED IN JAPAN
Authors: SHIRATORI Y ZHANG PY OHNO E PAYAWAL D NITTA S OKUDAIRA T KATO N IMAMURA T TERATANI T OBI S SHIINA S YOSHIDA H OMATA M
Citation: Y. Shiratori et al., COINFECTION OF HEPATITIS-B AND HEPATITIS-C VIRUSES PLAYS MUCH LESS ROLE IN DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA (HCC) THAN GENERALLY CLAIMED IN JAPAN, Gastroenterology, 110(4), 1996, pp. 1324-1324
GENOTYPES AMOUNT OF HCV, BACKGROUND LIVER-DISEASE AND HCC RECURRENCE/
Authors: KATO N SHIINA S IMAMURA M KANAI F OKUDAIRA T TERATANI T ZHANG PY YOSHIDA H KAWABE T OHTA S SHIRATORI Y OMATA M
Citation: N. Kato et al., GENOTYPES AMOUNT OF HCV, BACKGROUND LIVER-DISEASE AND HCC RECURRENCE/, Hepatology, 22(4), 1995, pp. 355-355
POWER DOPPLER EXAMINATION FOR CHARACTERIZATION OF HEPATOCELLULAR-CARCINOMA (HCC)
Authors: IMAMURA M TERATANI T OHASHI M KANAI F OKUDAIRA T KATO N NIWA Y SHIINA S KAWABE T OHTA S SHIRATORI Y OMATA M
Citation: M. Imamura et al., POWER DOPPLER EXAMINATION FOR CHARACTERIZATION OF HEPATOCELLULAR-CARCINOMA (HCC), Hepatology, 22(4), 1995, pp. 1302-1302
CHARACTERISTIC DIFFERENCE OF HEPATOCELLULAR-CARCINOMA BETWEEN HEPATITIS-B AND HEPATITIS-C VIRAL-INFECTION IN JAPAN
Authors: SHIRATORI Y SHIINA S IMAMURA M KATO N KANAI F OKUDAIRA T TERATANI T TOHGO G TODA N OHASHI M OGURA K NIWA Y KAWABE T OMATA M
Citation: Y. Shiratori et al., CHARACTERISTIC DIFFERENCE OF HEPATOCELLULAR-CARCINOMA BETWEEN HEPATITIS-B AND HEPATITIS-C VIRAL-INFECTION IN JAPAN, Hepatology, 22(4), 1995, pp. 1027-1033
Risultati: 1-24 |